Then and Now – Delivering a Successful Therapeutic to Patients
In today’s whirlwind of diagnostics, vaccines and therapeutics, we take a step back and look at how the world of development and manufacturing of biologics has […]
In today’s whirlwind of diagnostics, vaccines and therapeutics, we take a step back and look at how the world of development and manufacturing of biologics has […]
Get ready for EFIB 2021 by joining our launch webinar “How to accelerate biotech innovation for a sustainable future”. EuropaBio is pleased to announce this kick-off […]
Join the EuropaBio Healthcare Biotechnology Team for a dive into EU policies that impact your current operations and will shape your future strategies. With the ongoing […]
EuropaBio hosts a member-only discussion session looking at ambitions for innovation and business in China, and how this impacts both the EU and US. We […]
The EU Pharmaceutical Strategy is looking to improve patients’ access to therapies for challenging and rare conditions. The EU legislation on cross-border healthcare is an important […]
Sustainability in industrial biotech innovations: life cycle assessment and beyond Get ready for EFIB 2021 by attending the kick-off webinar “Sustainability in Industrial biotech innovations: Life Cycle […]
The European Biotech Week celebrates biotechnology, an innovative and vibrant sector launched by the discovery of the DNA molecule back in 1953. The first European Biotech […]
Save the date for this 14th edition!EFIB is the market leading annual event in Europe for Industrial Biotechnology and the Bioeconomy. Visit the dedicated website to […]
EuropaBio, the European Association for Bioindustries, is proud to continue our platform for engaging patient and industry alike on pertinent healthcare debates: the Patient Bio-Forum. In […]
At the time of the 25th Anniversary of EuropaBio, we would like to look to the future and the green transition that will shape healthcare for us all.
The ‘EFIB 2021 Vienna Statement’ marked the launch of an annual call to action from EuropaBio members, with policy asks and actions critical in the short […]
The existence of messenger(m) RNA was hypothesized early in the days of DNA breakthroughs in the 1960s, and research from the 1990s started to reveal its potential as a therapeutic tool.